Eisler Capital (UK)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $730K | Buy |
+3,766
| New | +$730K | ﹤0.01% | 84 |
|
|
2024
Q2 | – | Sell |
-5,520
| Closed | -$1.19M | – | 120 |
|
|
2024
Q1 | $1.19M | Sell |
5,520
-5,119
| -48% | -$1.1M | 0.01% | 170 |
|
|
2023
Q4 | $2.75M | Sell |
10,639
-23,052
| -68% | -$5.97M | 0.02% | 89 |
|
|
2023
Q3 | $8.66M | Buy |
33,691
+20,012
| +146% | +$5.14M | 0.05% | 65 |
|
|
2023
Q2 | $3.9M | Buy |
+13,679
| New | +$3.9M | 0.03% | 59 |
|
|
2022
Q4 | – | Sell |
-1,175
| Closed | -$314K | – | 98 |
|
|
2022
Q3 | $314K | Buy |
+1,175
| New | +$314K | 0.02% | 71 |
|
|
2022
Q2 | – | Sell |
-10,348
| Closed | -$2.18M | – | 352 |
|
|
2022
Q1 | $2.18M | Buy |
+10,348
| New | +$2.18M | 0.04% | 149 |
|